Prognosis

California Tightens Curbs; Cases Rise in 50 States: Virus Update

Moderna Vaccine Has 94.5% Efficacy, Trial Analysis Shows
Lock
This article is for subscribers only.

We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.

Moderna Inc. said a preliminary analysis of its Covid-19 vaccine suggested it’s almost 95% effective. It was another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control the pandemic.